Chris Reinhard of Cardium Therapuetics discusses ‘ the realities of novel gene therapy commercialization ‘ in this 2015 presentation . In this presentation, learn about Generx cardiac angiogenic gene therapy, a Phase III product candidate.
Download this presentation to understand more about:
- Preclinical research
- Clinical Safety & Technology
- Medical Utility
- Addressable Market
and much more!
Get your copy here!
If you’re interested in learning more about emerging gene therapy candidates , join us at World Precision Medicine Congress USA 2016 , held November 14-15 in Washington, DC .